{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-15T04:04:42.763537+00:00","company":{"ticker":"ZEOX","cik":1557376,"company_name":"Zeo ScientifiX, Inc."},"pagination":{"limit":100,"returned":27,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"AJB Capital Investments, LLC","detail":"equity_purchase","count":1,"first_seen":"2023-03-08T23:59:59+00:00","last_seen":"2023-03-08T23:59:59+00:00","evidence_fact_ids":[173165]}],"lender":[{"display_name":"AJB Capital Investments, LLC","detail":"loan","count":1,"first_seen":"2023-03-08T23:59:59+00:00","last_seen":"2023-03-08T23:59:59+00:00","evidence_fact_ids":[173168]}],"ma_counterparty":[{"display_name":"a non-affiliated third party purchaser","detail":"disposition","count":1,"first_seen":"2023-08-09T23:59:59+00:00","last_seen":"2023-08-09T23:59:59+00:00","evidence_fact_ids":[121509]}]},"facts":[{"fact_type":"executive_change","fact_key":"b40d4c8d8f","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2025-04-02T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-01","interim":false,"role":"Chief Sales Officer - Aesthetics","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Ron Borsheim was appointed as Chief Sales Officer - Aesthetics at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001829126-25-002326","anchor_url":"https://secwatch.observer/filing/0001829126-25-002326#claim-b40d4c8d8f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm"},{"fact_type":"executive_change","fact_key":"d2f9283aa8","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2025-02-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-02-07","interim":false,"role":"Chief Scientific and Technology Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Dr. Peter A. M. Everts was appointed as Chief Scientific and Technology Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective February 7, 2025, Dr. Peter A. M. Everts, Ph.D. (“ Dr. Everts” ) was appointed the Company’s Chief Scientific and Technology Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-25-000818","anchor_url":"https://secwatch.observer/filing/0001829126-25-000818#claim-d2f9283aa8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/0001829126-25-000818-index.htm"},{"fact_type":"governance_change","fact_key":"66e9d52d00ed7b86a75cbe9285540673fe22d7a3","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-12-19T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-12-17","item_codes_triggered":["5.03"],"summary_text":"Amended the Certificate of Designation of Series C Non-Convertible Preferred Stock to modify redemption provision"},"claim":"Zeo ScientifiX, Inc.: Amended the Certificate of Designation of Series C Non-Convertible Preferred Stock to modify redemption provision (effective 2024-12-17).","evidence_excerpt":"On December 17, 2024, we filed an Amendment (the “ Amendment ”) to the Certificate of Designation (the “ Certificate of Designation ”) of our Series C Non-Convertible Preferred Stock (the “ Series C Preferred Shares ”) with the Secretary of State of Nevada.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-24-008411","anchor_url":"https://secwatch.observer/filing/0001829126-24-008411#claim-66e9d52d00ed7b86a75cbe9285540673fe22d7a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624008411/0001829126-24-008411-index.htm"},{"fact_type":"executive_change","fact_key":"fd18b90c13","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-06-03T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-01","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Ian T. Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective June 1, 2024, our board of directors appointed Ian T. Bothwell, the Company’s Chief Financial Officer to serve in the additional position of Interim Chief Executive Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-24-003927","anchor_url":"https://secwatch.observer/filing/0001829126-24-003927#claim-fd18b90c13","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624003927/0001829126-24-003927-index.htm"},{"fact_type":"executive_change","fact_key":"63fe754d88","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-06-03T23:59:59+00:00","payload":{"action":"not renewed","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-05-31","interim":false,"role":"Chief Science Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Dr. Howard Golub departed as Chief Science Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-24-003927","anchor_url":"https://secwatch.observer/filing/0001829126-24-003927#claim-63fe754d88","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624003927/0001829126-24-003927-index.htm"},{"fact_type":"executive_change","fact_key":"0938128064","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-06-03T23:59:59+00:00","payload":{"action":"no longer serves","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-05-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dr. Harry Leider departed as Director at Zeo ScientifiX, Inc..","evidence_excerpt":"Dr. Leider no longer serves as a director of ZEO, as provided for therein.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-24-003927","anchor_url":"https://secwatch.observer/filing/0001829126-24-003927#claim-0938128064","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624003927/0001829126-24-003927-index.htm"},{"fact_type":"executive_change","fact_key":"ecc68ae904","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-06-03T23:59:59+00:00","payload":{"action":"not renewed","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-05-31","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Ian T. Bothwell","successor_named":true},"claim":"Dr. Harry Leider departed as Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"the employment agreements expired and the employment of Drs. Leider and Golub by the Company ended on May 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-24-003927","anchor_url":"https://secwatch.observer/filing/0001829126-24-003927#claim-ecc68ae904","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624003927/0001829126-24-003927-index.htm"},{"fact_type":"governance_change","fact_key":"2036500b8fb55a77d0576d81020fb9e3da7fcdb6","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-02-26T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-02-20","item_codes_triggered":["5.03"],"summary_text":"Changed company name from Organicell Regenerative Medicine, Inc. to Zeo ScientifiX, Inc."},"claim":"Zeo ScientifiX, Inc.: Changed company name from Organicell Regenerative Medicine, Inc. to Zeo ScientifiX, Inc (effective 2024-02-20).","evidence_excerpt":"The Company has filed an Amendment to its Articles of Incorporation (the “ Amendment ”) with the Secretary of State of Nevada, changing its name from “ Organicell Regenerative Medicine, Inc. ” to “ Zeo ScientifiX, Inc. ” effective February 20, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-24-001107","anchor_url":"https://secwatch.observer/filing/0001829126-24-001107#claim-2036500b8fb55a77d0576d81020fb9e3da7fcdb6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624001107/0001829126-24-001107-index.htm"},{"fact_type":"ma_transaction","fact_key":"5b9b229fd1fa1f0125d780c7313d5f6635bdac95","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-08-09T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2023-08-07","consideration_text":"$1,250,000 plus the assumption by Purchaser of all remaining financial and other obligations under the leases","counterparty":"a non-affiliated third party purchaser","effective_date":"2023-08-07","item_codes_triggered":["2.01"]},"claim":"Zeo ScientifiX, Inc. completed a disposition involving a non-affiliated third party purchaser for $1,250,000 plus the assumption by Purchaser of all remaining financial and other obligations under the leases (closed 2023-08-07).","evidence_excerpt":"the assignment of the leases for the Laboratory premises and certain laboratory equipment and the sale of leasehold\nimprovements and inventory. The purchase price paid was $1,250,000 plus the assumption by Purchaser of all remaining financial and other\nobligations under the leases for the Laboratory premises and certain laboratory equipment. In addition,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-23-005249","anchor_url":"https://secwatch.observer/filing/0001829126-23-005249#claim-5b9b229fd1fa1f0125d780c7313d5f6635bdac95","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623005249/0001829126-23-005249-index.htm"},{"fact_type":"executive_change","fact_key":"9811d576a9","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-07-11T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2023-07-11","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dr. Maria Ines Mitrani resigned as director at Zeo ScientifiX, Inc..","evidence_excerpt":"On July 11, 2023, Dr. Maria Ines Mitrani resigned as a director of the Company.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001829126-23-004629","anchor_url":"https://secwatch.observer/filing/0001829126-23-004629#claim-9811d576a9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623004629/0001829126-23-004629-index.htm"},{"fact_type":"executive_change","fact_key":"71d82db420","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-06-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-06-06","interim":false,"role":"Executive Vice President and Chief Science Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Howard J. Golub was appointed as Executive Vice President and Chief Science Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"and Howard J. Golub, M.D., as Executive Vice President and Chief Science Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-23-003953","anchor_url":"https://secwatch.observer/filing/0001829126-23-003953#claim-71d82db420","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm"},{"fact_type":"executive_change","fact_key":"0ca412577f","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-06-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-06-06","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Harry Leider was appointed as Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-23-003953","anchor_url":"https://secwatch.observer/filing/0001829126-23-003953#claim-0ca412577f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm"},{"fact_type":"executive_change","fact_key":"fb718282ec","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-06-06T23:59:59+00:00","payload":{"action":"stepped down","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2023-06-04","interim":false,"role":"Chairman of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Bhupendra Kumar Modi departed as Chairman of the Board at Zeo ScientifiX, Inc..","evidence_excerpt":"On June 4, 2023, Dr. Bhupendra Kumar Modi stepped down as Chairman of the Board and a director of Organicell.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-23-003953","anchor_url":"https://secwatch.observer/filing/0001829126-23-003953#claim-fb718282ec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003953/0001829126-23-003953-index.htm"},{"fact_type":"executive_change","fact_key":"2d7565a238","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-05-15T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2023-05-12","interim":false,"role":"Executive Vice President of Sales","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Albert Mitrani was terminated as Executive Vice President of Sales at Zeo ScientifiX, Inc..","evidence_excerpt":"On May 12, 2023, Organicell terminated Albert Mitrani as its Executive Vice President of Sales and contemporaneously terminated his employment agreement with the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-23-003436","anchor_url":"https://secwatch.observer/filing/0001829126-23-003436#claim-2d7565a238","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003436/0001829126-23-003436-index.htm"},{"fact_type":"executive_change","fact_key":"b02acddf5e","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-05-01T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2023-04-28","interim":false,"role":"Chief Scientific Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Maria Ines Mitrani was terminated as Chief Scientific Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"On April 28, 2023, Organicell terminated Dr. Maria Ines Mitrani as its Chief Scientific Officer and contemporaneously terminated her employment agreement with the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-23-003036","anchor_url":"https://secwatch.observer/filing/0001829126-23-003036#claim-b02acddf5e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623003036/0001829126-23-003036-index.htm"},{"fact_type":"auditor_change","fact_key":"b7e8a70aa5c3767fb17a43d4a14343cc05bdce56","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-04-21T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Weinberg & Company P.A.","disagreement_text":null,"effective_date":"2023-04-17","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Zeo ScientifiX, Inc. engaged Weinberg & Company P.A. as its auditor.","evidence_excerpt":"On April 17 2023, the Audit Committee of our Board of Directors approved the appointment of Weinberg & Company P.A. (\" Weinberg \") as the Company’s new independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-23-002882","anchor_url":"https://secwatch.observer/filing/0001829126-23-002882#claim-b7e8a70aa5c3767fb17a43d4a14343cc05bdce56","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623002882/0001829126-23-002882-index.htm"},{"fact_type":"debt_financing","fact_key":"a68c3182dd95928d598f575f7bba8bc28b2ff045","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-03-08T23:59:59+00:00","payload":{"counterparty":"AJB Capital Investments, LLC","effective_date":"2023-03-06","event":"incurrence","instrument_type":"loan","interest_rate_text":"12% per annum","item_codes_triggered":["2.03"],"maturity_text":"September 6, 2023","principal_text":"$530,000"},"claim":"Zeo ScientifiX, Inc. incurred loan of $530,000 with AJB Capital Investments, LLC at 12% per annum maturing September 6, 2023.","evidence_excerpt":"On March 6, 2023, the Company entered into a Securities Purchase Agreement (the “ SPA ”) with AJB Capital Investments, LLC (the “ Purchaser ”), pursuant to which we sold a Promissory Note in the principal amount of $530,000 (the “ Note ”) to the Purchaser in a private transaction to for a purchase price of $519,400 (giving effect to original issue discount of $10,600).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-23-001912","anchor_url":"https://secwatch.observer/filing/0001829126-23-001912#claim-a68c3182dd95928d598f575f7bba8bc28b2ff045","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623001912/0001829126-23-001912-index.htm"},{"fact_type":"material_agreement","fact_key":"f93232a5d9bd2d77f13973bfd4cb5d618c5f937b","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2023-03-08T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"equity_purchase","counterparty":"AJB Capital Investments, LLC","effective_date":"2023-03-06","item_codes_triggered":["1.01"],"value_text":"$530,000"},"claim":"Zeo ScientifiX, Inc. entered into Securities Purchase Agreement with AJB Capital Investments, LLC valued at $530,000 (effective 2023-03-06).","evidence_excerpt":"On March 6, 2023, the Company entered into a Securities Purchase Agreement (the \" SPA \") with AJB Capital Investments, LLC (the \" Purchaser \"), pursuant to which we sold a Promissory Note in the principal amount of $530,000","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-23-001912","anchor_url":"https://secwatch.observer/filing/0001829126-23-001912#claim-f93232a5d9bd2d77f13973bfd4cb5d618c5f937b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623001912/0001829126-23-001912-index.htm"},{"fact_type":"executive_change","fact_key":"dcb82faff6","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-12-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2022-12-21","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"John Chiste resigned as Director at Zeo ScientifiX, Inc..","evidence_excerpt":"On December 21, 2022, John Chiste resigned as a member of the Company’s board of directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-020516","anchor_url":"https://secwatch.observer/filing/0001829126-22-020516#claim-dcb82faff6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622020516/0001829126-22-020516-index.htm"},{"fact_type":"executive_change","fact_key":"2402e3c504","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-12-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-11-29","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Ian Bothwell was appointed as Interim Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"The Board also agreed to appoint Mr. Ian Bothwell, the Company’s Chief Financial Officer to serve as the Company’s Interim Chief Executive Officer while the Board commences its process to identify suitable candidates to fill the Chief Executive Officer position.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-019616","anchor_url":"https://secwatch.observer/filing/0001829126-22-019616#claim-2402e3c504","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/0001829126-22-019616-index.htm"},{"fact_type":"executive_change","fact_key":"59176246c1","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-12-01T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-11-29","interim":false,"role":"Acting Chief Executive Officer and President","role_category":"ceo","successor_name":"Ian Bothwell","successor_named":true},"claim":"Matthew Sinnreich resigned as Acting Chief Executive Officer and President at Zeo ScientifiX, Inc..","evidence_excerpt":"On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-019616","anchor_url":"https://secwatch.observer/filing/0001829126-22-019616#claim-59176246c1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019616/0001829126-22-019616-index.htm"},{"fact_type":"executive_change","fact_key":"4d3a99d8d0","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-11-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2022-11-22","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Ryan Likes resigned as Chief Operating Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"On November 22, 2022, Ryan Likes resigned as the Company’s Chief Operating Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-019494","anchor_url":"https://secwatch.observer/filing/0001829126-22-019494#claim-4d3a99d8d0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622019494/0001829126-22-019494-index.htm"},{"fact_type":"executive_change","fact_key":"814ce472ec","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-09-27T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-09-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Matthew Sinnreich was appointed as Director at Zeo ScientifiX, Inc..","evidence_excerpt":"At a meeting held on September 23, 2022, the Company’s board of directors (the “ Board ”) expanded the number of directors of the Company to thirteen (13) and appointed the following individuals to fill existing and newly-created vacancies on the Board: ● Matthew Sinnreich, our President and Acting Chief Executive Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-017221","anchor_url":"https://secwatch.observer/filing/0001829126-22-017221#claim-814ce472ec","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622017221/0001829126-22-017221-index.htm"},{"fact_type":"executive_change","fact_key":"2470c68aa8","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-09-15T23:59:59+00:00","payload":{"action":"assumed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-09-13","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Matthew Sinnreich changed role as President at Zeo ScientifiX, Inc..","evidence_excerpt":"Matthew Sinnreich, the Company’s current Chief Operating Officer and Acting Chief Executive Officer assumed the role of President and will continue as Organicell’s Acting Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-016892","anchor_url":"https://secwatch.observer/filing/0001829126-22-016892#claim-2470c68aa8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622016892/0001829126-22-016892-index.htm"},{"fact_type":"executive_change","fact_key":"04865ce29b","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-09-15T23:59:59+00:00","payload":{"action":"joined","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-09-13","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Ryan Likes was appointed as Chief Operating Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective September 13, 2022, Ryan Likes had joined the Company as its Chief Operating Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-016892","anchor_url":"https://secwatch.observer/filing/0001829126-22-016892#claim-04865ce29b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622016892/0001829126-22-016892-index.htm"},{"fact_type":"executive_change","fact_key":"c9da568a30","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-07-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-07-21","interim":true,"role":"Chief Operating Officer and Acting Chief Executive Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Matthew Sinnreich was appointed as Chief Operating Officer and Acting Chief Executive Officer at Zeo ScientifiX, Inc..","evidence_excerpt":"On the Effective Date, Matthew Sinnreich was appointed by the Board of Directors to the position of Chief Operating Officer and Acting Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-014634","anchor_url":"https://secwatch.observer/filing/0001829126-22-014634#claim-c9da568a30","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622014634/0001829126-22-014634-index.htm"},{"fact_type":"executive_change","fact_key":"0baa3e81d7","cik":1557376,"ticker":"ZEOX","company_name":"Zeo ScientifiX, Inc.","filed_at":"2022-07-26T23:59:59+00:00","payload":{"action":"stepped down as Chief Executive Officer and appointed Executive Vice President of Sales","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-07-21","interim":false,"role":"Executive Vice President of Sales","role_category":"other_named_officer","successor_name":"Matthew Sinnreich","successor_named":true},"claim":"Albert Mitrani was appointed as Executive Vice President of Sales at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective July 21, 2022 (the “ Effective Date ”), Albert Mitrani stepped down as the Company’s Chief Executive Officer and was appointed by the Board of Directors to the position of Executive Vice President of Sales.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001829126-22-014634","anchor_url":"https://secwatch.observer/filing/0001829126-22-014634#claim-0baa3e81d7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912622014634/0001829126-22-014634-index.htm"}]}